SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MAXY - Maxygen, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: rkrw who wrote (243)6/15/2007 12:10:51 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 262
 
NVO’s NN1731 is further along in development.



To: rkrw who wrote (243)6/19/2007 3:31:53 PM
From: dr.praveen  Respond to of 262
 
Maxy had decided to advance MAXY-VII into hemophilia
on its own with an IND targeted for early 08. Looks like they r
trying to put their Codexis dollars to work!

Edit: Seems like 08 is the make or break year for them.